Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Cristiano Felicetti"'
Autor:
Carolina Liguori, Cecilia Copparoni, Cristiano Felicetti, Federica Pecci, Alessio Lupi, Giada Pinterpe, Rossana Berardi, Riccardo Giampieri
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 1032-1045 (2023)
Background: Unresectable cholangiocarcinoma prognosis can be extremely variable due to different symptoms and sites of disease involvement at diagnosis and unpredictable chemotherapy response rates. Most patients will usually receive 1st line palliat
Externí odkaz:
https://doaj.org/article/d527a992966943d290372e676efa6632
Autor:
Alessandro Parisi, Riccardo Giampieri, Alex Mammarella, Cristiano Felicetti, Lisa Salvatore, Maria Bensi, Maria Grazia Maratta, Antonia Strippoli, Roberto Filippi, Maria Antonietta Satolli, Angelica Petrillo, Bruno Daniele, Michele De Tursi, Pietro Di Marino, Guido Giordano, Matteo Landriscina, Pasquale Vitale, Ina Valeria Zurlo, Emanuela Dell’Aquila, Silverio Tomao, Ilaria Depetris, Francesca Romana Di Pietro, Federica Zoratto, Davide Ciardiello, Maria Vittoria Pensieri, Ornella Garrone, Barbara Galassi, Claudio Ferri, Rossana Berardi, Michele Ghidini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimThe aim of the current study is to investigate the impact of primary compared to secondary chemotherapy-induced nausea and vomiting (CINV) prophylaxis with NK1 receptor antagonists (NK1-RA) in patients affected by gastrointestinal malignancies and
Externí odkaz:
https://doaj.org/article/a870c172dbe94deaa83affaa21374c17
Autor:
Valeria Cognigni, Federica Pecci, Alessio Lupi, Giada Pinterpe, Chiara De Filippis, Cristiano Felicetti, Luca Cantini, Rossana Berardi
Publikováno v:
Cancers, Vol 14, Iss 19, p 4765 (2022)
During the last decade, the identification of oncogenic driver mutations and the introduction of tyrosine kinase inhibitors (TKIs) in daily clinical practice have substantially revamped the therapeutic approach of oncogene-addicted, non-small cell lu
Externí odkaz:
https://doaj.org/article/1379afe2176f4813ac32af02cde1c772